Contributors |
|
xv | |
Editors Biography |
|
xix | |
Foreword |
|
xxi | |
Preface |
|
xxiii | |
Part I Probiotics Microorganisms |
|
|
1 Probiotic Microorganisms and Their Benefit to Human Health |
|
|
|
|
|
|
|
3 | (1) |
|
2 Most common detection methods and assays of probiotic microorganisms |
|
|
4 | (2) |
|
|
4 | (2) |
|
2.2 In vivo animal assays |
|
|
6 | (1) |
|
|
6 | (1) |
|
3 Probiotic microorganisms and their recently reported health effects |
|
|
6 | (9) |
|
3.1 Probiotics, the genus Lactobacillus, and novel lactobacilli genera |
|
|
6 | (4) |
|
3.2 Probiotics and the genus Bifidobacterium |
|
|
10 | (2) |
|
3.3 Genera of probiotic lactic acid bacteria other than lactobacilli |
|
|
12 | (1) |
|
3.4 Genera of other probiotic bacteria and yeasts |
|
|
13 | (1) |
|
3.5 Novel or next-generation probiotics |
|
|
14 | (1) |
|
4 Discussion and conclusions |
|
|
15 | (1) |
|
|
15 | (8) |
|
2 Selection Criteria for Identifying Putative Probiont |
|
|
|
|
|
|
|
|
23 | (1) |
|
2 Probiotic microorganisms |
|
|
24 | (1) |
|
3 Requirements for the selection of probiotic strains |
|
|
25 | (3) |
|
3.1 Survival during gastrointestinal transit |
|
|
26 | (1) |
|
3.2 Adhesion to gut cells |
|
|
26 | (1) |
|
3.3 Antipathogenic activity |
|
|
27 | (1) |
|
|
28 | (2) |
|
|
29 | (1) |
|
4.2 Antibiotic resistance |
|
|
29 | (1) |
|
4.3 Taxonomy/Identification |
|
|
30 | (1) |
|
5 Technological requirements |
|
|
30 | (1) |
|
|
31 | (1) |
|
|
32 | (5) |
|
3 Simulated Gastrointestinal System to Assess the Probiotic Properties Modified to Encapsulation of Probiotics and Their Survival Under Simulated Gastrointestinal System |
|
|
|
|
|
|
|
37 | (1) |
|
2 The gastrointestinal (GI) tract |
|
|
38 | (1) |
|
2.1 Microbiota of the adult GI tract |
|
|
38 | (1) |
|
2.2 Characteristics of the GI tract for probiotic delivery |
|
|
38 | (1) |
|
3 Encapsulation technologies for probiotics |
|
|
39 | (2) |
|
3.1 Selecting the biomaterials for microencapsulation |
|
|
40 | (1) |
|
4 Selecting the in vitro conditions for cells release |
|
|
41 | (1) |
|
5 Survival of entrapped LCS in simulated gastrointestinal conditions |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
43 | (2) |
|
4 Next-Generation Probiotics |
|
|
|
|
|
|
45 | (1) |
|
2 Next-generation probiotics |
|
|
46 | (1) |
|
2.1 Need for next-generation probiotics |
|
|
46 | (1) |
|
3 Candidates for next-generation probiotics |
|
|
47 | (21) |
|
3.1 Akkermansia muciniphila |
|
|
47 | (8) |
|
|
55 | (3) |
|
3.3 Faecalibacterium prausnitzii |
|
|
58 | (6) |
|
|
64 | (2) |
|
3.5 Parabacteroides goldsteinii |
|
|
66 | (2) |
|
4 Safety assessment of next-generation probiotics |
|
|
68 | (1) |
|
5 Application of next-generation probiotics |
|
|
69 | (2) |
|
|
69 | (1) |
|
|
69 | (1) |
|
5.3 Regulatory challenges |
|
|
70 | (1) |
|
|
71 | (1) |
|
|
71 | (10) |
|
5 Edible Mushrooms: A Promising Bioresource for Prebiotics |
|
|
|
Karthiyayini Balakrishnan |
|
|
Dharumadurai Dhanasekaran |
|
|
|
|
|
|
|
81 | (12) |
|
1.1 Mushrooms as food values |
|
|
83 | (1) |
|
1.2 Energy value of mushrooms |
|
|
83 | (1) |
|
|
84 | (1) |
|
1.4 Bioactive compounds of mushrooms |
|
|
84 | (1) |
|
1.5 Low-molecular and high-molecular weight compounds in mushroom |
|
|
84 | (2) |
|
1.6 Importance of prebiotics |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
1.9 Benefits of prebiotics |
|
|
87 | (1) |
|
1.10 Properties of prebiotics |
|
|
87 | (1) |
|
1.11 Characteristics of ideal prebiotics |
|
|
88 | (1) |
|
1.12 Mechanism of prebiotics |
|
|
88 | (1) |
|
1.13 Potential immunomodulatory mechanism of prebiotics |
|
|
89 | (1) |
|
1.14 Gastrointestinal effects of prebiotics |
|
|
89 | (1) |
|
1.15 Effects of prebiotic in gastrointestinal |
|
|
90 | (1) |
|
1.16 Mushrooms as a promising prebiotic |
|
|
90 | (2) |
|
1.17 Criteria of prebiotics |
|
|
92 | (1) |
|
1.18 Role of mushrooms as prebiotics |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
94 | (7) |
Part II Omics approaches in Probiotics |
|
|
6 Genetic Modification and Sequence Analysis of Probiotic Microorganisms |
|
|
|
|
|
|
|
|
101 | (1) |
|
|
102 | (1) |
|
3 Genetic engineering applications on probiotic strains |
|
|
103 | (4) |
|
|
103 | (2) |
|
|
105 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
107 | (1) |
|
4 Use of CRISPR-Cas systems |
|
|
107 | (1) |
|
5 Systems biology approaches |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
110 | (3) |
|
7 Biosynthetic Gene Cluster Analysis in Lactobacillus Species Using antiSMASH |
|
|
|
|
Dharumadurai Dhanasekaran |
|
|
|
113 | (1) |
|
2 In vitro and in vivo studies on beneficial effects of probiotics |
|
|
114 | (1) |
|
2.1 Bowel diseases and the immune system |
|
|
114 | (1) |
|
|
114 | (1) |
|
|
114 | (1) |
|
3 Modulation of gut-brain axis by probiotics |
|
|
114 | (1) |
|
|
114 | (1) |
|
4.1 Selection of genes from GenBank |
|
|
114 | (1) |
|
|
115 | (1) |
|
5 Secondary metabolite clusters identification using antiSMASH |
|
|
115 | (1) |
|
6 Phylogenetic analysis of genes |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
8.1 Selection of genes from Gen Bank |
|
|
115 | (1) |
|
|
115 | (1) |
|
9 Secondary metabolite clusters identification using antiSMASH |
|
|
116 | (1) |
|
10 Phylogenetic analysis of genes |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
119 | (2) |
|
8 Probiotic Polysaccharides as Toll-Like Receptor 4 Modulators-An In Silico Strategy |
|
|
|
|
|
|
121 | (1) |
|
|
122 | (2) |
|
|
122 | (1) |
|
2.2 Protein and Iigand preparation |
|
|
123 | (1) |
|
2.3 Molecular docking and prime MM/GMSA |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
124 | (8) |
|
|
124 | (3) |
|
|
127 | (1) |
|
|
127 | (5) |
|
|
132 | (1) |
|
|
132 | (5) |
Part III Quality and Nutrition of Probiotics |
|
|
9 Prebiotics Mechanism of Action: An Over View |
|
|
|
|
|
Shunmugiah Karutha Pandian |
|
|
|
137 | (1) |
|
2 Mechanism of prebiotics in treating constipation |
|
|
138 | (1) |
|
3 Mechanism of action of prebiotics in maintaining intestinal pH |
|
|
138 | (1) |
|
4 Mechanism of action of prebiotics in maintaining lipid metabolism |
|
|
138 | (1) |
|
5 Mechanism of action of prebiotics as anticarcinogenic agents |
|
|
139 | (1) |
|
6 Mechanism of action of prebiotics in immunomodulation |
|
|
139 | (1) |
|
7 Mechanism of action of prebiotics in preventing necrotizing enterocolitis (NEC) |
|
|
140 | (1) |
|
8 Mechanism of action of prebiotics in preventing diabetes |
|
|
140 | (1) |
|
9 Mechanism of action of prebiotics in preventing bowel diseases |
|
|
140 | (1) |
|
10 Mechanism of prebiotics in improving nutritional absorption |
|
|
141 | (1) |
|
11 Mechanism of action of prebiotics in maintaining nervous system |
|
|
142 | (1) |
|
12 Mechanism of action of prebiotics in preventing autism |
|
|
142 | (1) |
|
13 Mechanism of action of prebiotics in preventing hepatic encephalopathy |
|
|
142 | (1) |
|
14 Mechanism of action of prebiotics in preventing skin diseases |
|
|
143 | (1) |
|
15 Mechanism of action of prebiotics in preventing cardiovascular diseases |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
143 | (6) |
|
10 Synbiotics in Nutrition |
|
|
|
|
Mohamed Yousuff Mohamed Imran |
|
|
|
Dharumadurai Dhanasekaran |
|
|
|
149 | (1) |
|
|
149 | (1) |
|
3 Synbiotic selection criteria |
|
|
150 | (1) |
|
|
150 | (1) |
|
5 Mechanism of action of synbiotics |
|
|
150 | (1) |
|
|
151 | (1) |
|
7 Synbiotics and their outcomes on human health in clinical studies |
|
|
152 | (1) |
|
|
152 | (1) |
|
9 Inflammatory bowel disease |
|
|
152 | (1) |
|
|
153 | (1) |
|
11 Irritable bowel syndrome |
|
|
154 | (1) |
|
|
154 | (1) |
|
13 Kidney and liver disease |
|
|
155 | (1) |
|
14 Synbiotics for animals |
|
|
155 | (1) |
|
|
156 | (1) |
|
16 Application of synbiotics |
|
|
156 | (1) |
|
17 Commercial synbiotics: obstacles, challenges, and future prospects |
|
|
157 | (1) |
|
18 The safety issue of synbiotics |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
158 | (5) |
|
11 Role of Probiotic Microbes Exerting Nutritional Properties |
|
|
|
|
Alwarappan Sankaranarayanan |
|
|
|
163 | (1) |
|
2 Overview about probiotic foods |
|
|
164 | (3) |
|
3 Probiotic food products |
|
|
167 | (5) |
|
3.1 Dairy-based probiotic foods |
|
|
169 | (2) |
|
3.2 Nondairy probiotic products |
|
|
171 | (1) |
|
4 Microbial role in probiotic foods and nutritional properties |
|
|
172 | (2) |
|
5 Probiotic food and its clinical significance-human health perspectives |
|
|
174 | (2) |
|
5.1 Antimicrobial potential of probiotic foods |
|
|
174 | (1) |
|
5.2 Antiinflammatory activity of probiotic food and human health |
|
|
174 | (1) |
|
5.3 Antiobesity and probiotic foods |
|
|
175 | (1) |
|
5.4 Probiotic food and antidiabetic activities |
|
|
175 | (1) |
|
5.5 Anticancer properties of probiotic foods |
|
|
175 | (1) |
|
5.6 Probiotic foods and its effect on brain and CNS |
|
|
175 | (1) |
|
6 Role of probiotics in dietary supplements |
|
|
176 | (1) |
|
7 Global emergence of probiotic foods |
|
|
176 | (1) |
|
8 Nutraceutical importance of probiotic foods |
|
|
177 | (1) |
|
9 Future perspectives of probiotic foods |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
178 | (9) |
Part IV Probiotics in Health and Diseases |
|
|
12 Probiotic Microorganism: A Promising and Innovative Tool for Cancer Prevention and Therapy |
|
|
|
|
|
|
|
187 | (1) |
|
2 Chronic inflammation is a major oncogenic stimulant |
|
|
188 | (1) |
|
3 Mechanism of action of probiotics against cancer |
|
|
189 | (3) |
|
3.1 Modulation of oxidative stress |
|
|
189 | (1) |
|
3.2 Effects on carcinogen/genotoxic compounds |
|
|
190 | (1) |
|
3.3 Effects on bacterial enzymatic activity |
|
|
190 | (1) |
|
3.4 Immunomodulatory functions against cancer |
|
|
191 | (1) |
|
3.5 Effects of probiotics on tumor microenvironment |
|
|
191 | (1) |
|
3.6 Effects of probiotics on apoptosis |
|
|
191 | (1) |
|
4 In vitro studies of probiotics on cancer |
|
|
192 | (1) |
|
5 In vivo studies of probiotics on cancer |
|
|
193 | (2) |
|
6 Probiotics and gastrointestinal (GI) cancer |
|
|
195 | (1) |
|
6.1 Probiotics against colorectal cancer (CRC) |
|
|
195 | (1) |
|
6.2 Probiotics against gastric cancer (GC) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (7) |
|
13 Psychobiotics: A Newer Approach Toward the Treatment of Neurodevelopmental Disorders |
|
|
|
|
|
|
|
|
203 | (1) |
|
2 Gut microbiota as psychobiotics |
|
|
204 | (1) |
|
3 Prebiotics for psychobiotics |
|
|
205 | (1) |
|
4 Psychophysiological effects of psychobiotics |
|
|
205 | (1) |
|
5 Microbes-brain signaling |
|
|
206 | (1) |
|
6 Mind-enteric nervous system interaction |
|
|
207 | (1) |
|
|
207 | (1) |
|
8 Short-chain fatty acids, gut hormones, and bacteria-derived blood metabolites |
|
|
208 | (1) |
|
9 Microbes immune interactions |
|
|
209 | (1) |
|
10 Neuropsychological disorders |
|
|
210 | (1) |
|
|
211 | (1) |
|
12 Gastro Intestinal Issue |
|
|
212 | (1) |
|
13 Regulation of microbiota and possibilities for treatment |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (4) |
|
14 Probiotics, Diet, and Gut Microbiome Modulation in Metabolic Syndromes Prevention |
|
|
|
|
|
|
|
|
|
217 | (4) |
|
1.1 Metabolic syndrome and diet |
|
|
218 | (3) |
|
2 Unveiling the potential of probiotics |
|
|
221 | (1) |
|
2.1 Probiotics and dysbiosis |
|
|
222 | (1) |
|
3 Gut microbiota in obesity |
|
|
222 | (5) |
|
3.1 Probiotics and obesity |
|
|
223 | (4) |
|
4 Probiotics and cardiovascular diseases |
|
|
227 | (1) |
|
|
228 | (1) |
|
|
228 | (5) |
|
15 Bacillus Species-Elucidating the Dilemma on Their Probiotic and Pathogenic Traits |
|
|
|
|
|
|
233 | (1) |
|
2 Advantages of sporeformers in the gut and food chain |
|
|
234 | (1) |
|
3 Probiotic attributes of Bacillus species |
|
|
234 | (3) |
|
4 Synbiotics of Bacillus sp. |
|
|
237 | (1) |
|
5 The rationale to use synbiotics |
|
|
237 | (2) |
|
6 Mechanism of action of Bacillus probiotics |
|
|
239 | (1) |
|
7 Mechanism 1-antimicrobial activity |
|
|
239 | (1) |
|
8 Mechanism 2-interaction with intestinal and immune cells |
|
|
240 | (1) |
|
9 Commercially available Bacillus probiotics |
|
|
240 | (1) |
|
10 Pathogenic attributes of Bacillus sp. |
|
|
241 | (1) |
|
11 Bacillus probiotics-safety |
|
|
242 | (1) |
|
|
243 | (1) |
|
|
243 | (4) |
|
16 Probiotic Fortified Seaweed Silage as Feed Supplement in Marine Hatcheries |
|
|
|
Charles Santhanaraju Vairappan |
|
|
|
247 | (1) |
|
2 Issues in aquaculture hatcheries |
|
|
247 | (1) |
|
3 Use of probiotics in aquaculture |
|
|
248 | (1) |
|
4 Seaweed probiotic fermentation |
|
|
249 | (1) |
|
5 Probiotic fortifies seaweed silage of Eucheuma denticulatum Doty |
|
|
250 | (3) |
|
6 Chemical characteristics of seaweed silage |
|
|
253 | (1) |
|
7 Seaweed silage as rotifer feed |
|
|
253 | (1) |
|
8 Seaweed silage feed formulation |
|
|
254 | (2) |
|
|
256 | (1) |
|
|
257 | (2) |
|
17 Secondary Metabolites From Probiotic Metabolism |
|
|
|
|
|
|
|
|
259 | (1) |
|
|
260 | (4) |
|
2.1 Postbiotic classification |
|
|
261 | (3) |
|
3 Conditions of probiotics to produce postbiotics |
|
|
264 | (1) |
|
3.1 Culture media composition |
|
|
264 | (1) |
|
3.2 Cultivation parameters |
|
|
265 | (1) |
|
4 Human health benefits of probiotics and postbiotics |
|
|
265 | (1) |
|
5 Application of probiotics and postbiotics for healthy food development |
|
|
266 | (4) |
|
|
270 | (1) |
|
|
270 | (7) |
|
18 Bacteriocins Produced by Probiotic Microorganisms |
|
|
|
|
|
277 | (1) |
|
|
278 | (1) |
|
3 Gram-negative bacteriocins |
|
|
279 | (1) |
|
4 Gram-positive bacteriocins |
|
|
280 | (4) |
|
4.1 Class I bacteriocins (modified peptides) |
|
|
281 | (1) |
|
4.2 Class II bacteriocins (unmodified peptides) |
|
|
281 | (1) |
|
4.3 Class III bacteriocins (large proteins) |
|
|
281 | (3) |
|
5 The mechanism of antibacterial activity of bacteriocins |
|
|
284 | (1) |
|
6 Applications of bacteriocins |
|
|
285 | (3) |
|
|
285 | (1) |
|
|
286 | (1) |
|
|
286 | (2) |
|
|
288 | (1) |
|
|
289 | (4) |
|
19 Probioactives: Bacteriocin and Exopolysaccharides |
|
|
|
|
|
|
|
293 | (1) |
|
2 Probioactive perception |
|
|
293 | (1) |
|
3 Sources and strain specificity of probioactives |
|
|
294 | (1) |
|
4 Bacteriocin from probiotic strains |
|
|
294 | (1) |
|
5 Bacteriocin classification |
|
|
295 | (1) |
|
6 Biochemical characterization of bacteriocin |
|
|
295 | (1) |
|
7 Bacteriocin genetics and biosynthesis |
|
|
295 | (1) |
|
8 Cytotoxicity effect of bacteriocin |
|
|
296 | (1) |
|
9 Bacteriocin from Lactobacillus sp. |
|
|
296 | (1) |
|
10 Gassericin from Lactobacillus gasseri |
|
|
297 | (1) |
|
11 Bacteriocin from Bacillus species |
|
|
297 | (1) |
|
12 Subtilosin A from Bacillus subtilis |
|
|
297 | (1) |
|
13 Bacterial exopolysaccharides |
|
|
298 | (1) |
|
|
298 | (1) |
|
|
298 | (2) |
|
16 Biosynthesis and genetics of EPS |
|
|
300 | (1) |
|
|
301 | (1) |
|
18 Physicochemical properties of EPS |
|
|
301 | (1) |
|
19 Biological properties of bacterial EPS |
|
|
302 | (1) |
|
20 Immunostimulatory activity |
|
|
302 | (1) |
|
|
302 | (1) |
|
|
302 | (1) |
|
23 Cholesterol-lowering activity |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
303 | (6) |
|
20 Probiotics in Shrimp Aquaculture |
|
|
|
|
|
|
|
309 | (1) |
|
|
309 | (1) |
|
|
309 | (1) |
|
4 Microorganisms of probiotic |
|
|
310 | (1) |
|
5 Probiotics in aquaculture |
|
|
310 | (1) |
|
5.1 Mechanisms of probiotics |
|
|
310 | (1) |
|
5.2 Competitive exclusion |
|
|
311 | (1) |
|
5.3 Nutrient and enzymatic contributions to digestion |
|
|
311 | (1) |
|
6 Immune system promoters |
|
|
311 | (1) |
|
7 Water quality improvement |
|
|
311 | (1) |
|
|
311 | (1) |
|
|
312 | (1) |
|
10 Probiotic feed preparation |
|
|
312 | (1) |
|
10.1 Tank culture experiments |
|
|
312 | (1) |
|
11 Assessment of physicochemical parameters |
|
|
313 | (1) |
|
12 Assessment of growth performance |
|
|
313 | (1) |
|
13 Results and discussion |
|
|
313 | (1) |
|
14 Determination of physicochemical parameters of probiotics supplemented shrimp aquaculture tank with various days of incubation |
|
|
314 | (3) |
|
15 Biochemical analysis of Litopenaeus vannamei by the effect of potential bacteria in different intervals |
|
|
317 | (3) |
|
16 Application of probiotics |
|
|
320 | (1) |
|
17 Hydrogen peroxide (H2O2) |
|
|
321 | (1) |
|
18 Influence of immune system |
|
|
321 | (1) |
|
19 Effect of reproduction of aquatic species |
|
|
322 | (1) |
|
|
322 | (1) |
|
|
323 | (4) |
|
21 Prospective Approaches of Pseudonocardia alaniniphila Hydrobionts for Litopenaeus vannamei |
|
|
|
|
|
|
|
|
|
|
|
327 | (1) |
|
|
327 | (1) |
|
|
327 | (1) |
|
|
328 | (1) |
|
1.4 Control of shrimp pathogen |
|
|
328 | (1) |
|
1.5 Probiotics: definition and principles |
|
|
328 | (1) |
|
|
328 | (4) |
|
|
328 | (1) |
|
|
329 | (1) |
|
2.3 Analysis of physicochemical parameters in soil |
|
|
329 | (1) |
|
2.4 Isolation and identification of Actinobacteria |
|
|
329 | (1) |
|
2.5 Determination of antimicrobial activity |
|
|
330 | (1) |
|
2.6 Molecular characterization of potential Actinobacteria |
|
|
331 | (1) |
|
2.7 Experimental design and feeding management |
|
|
331 | (1) |
|
2.8 Analysis of physicochemical parameters in water samples |
|
|
332 | (1) |
|
2.9 Growth and development of Litopenaeus vannamei |
|
|
332 | (1) |
|
2.10 Biochemical analysis |
|
|
332 | (1) |
|
2.11 Immunological studies |
|
|
332 | (1) |
|
|
332 | (10) |
|
3.1 Physicochemical properties of soil sample |
|
|
333 | (1) |
|
|
333 | (1) |
|
|
333 | (1) |
|
3.4 Electrical conductivity and cation exchange capacity |
|
|
334 | (1) |
|
3.5 Organic carbon and organic matter |
|
|
334 | (1) |
|
|
334 | (1) |
|
|
334 | (1) |
|
3.8 Isolation and identification of Actinobacteria from the mangrove soil samples |
|
|
334 | (3) |
|
3.9 Screening of antimicrobial activity against human pathogen |
|
|
337 | (1) |
|
3.10 Shrimp pathogen activity |
|
|
337 | (1) |
|
3.11 Antibiotic sensitivity test |
|
|
338 | (1) |
|
3.12 Molecular characterization of Actinobacterial strain |
|
|
339 | (1) |
|
|
339 | (3) |
|
|
342 | (4) |
|
|
346 | (3) |
|
22 Probiotics as a Growth Promotant for Livestock and Poultry Production |
|
|
|
|
Dharumadurai Dhanasekaran |
|
|
|
349 | (1) |
|
2 Exploitation of antibiotics in poultry production |
|
|
349 | (3) |
|
2.1 Antibiotics and microbial resistance |
|
|
350 | (1) |
|
2.2 Impact of antibiotic on the environment and consumer health |
|
|
350 | (1) |
|
2.3 Alternatives to the usage of antibiotics |
|
|
351 | (1) |
|
3 Probiotics: definition, concepts, and history |
|
|
352 | (2) |
|
3.1 Microbes used as animal probiotics |
|
|
352 | (2) |
|
4 Probiotics for poultry nutrition: a glance on the market |
|
|
354 | (2) |
|
4.1 Selection of probiotics |
|
|
355 | (1) |
|
5 Role of probiotics in poultry |
|
|
356 | (2) |
|
6 Bacterial populations in GI tract of poultry |
|
|
358 | (1) |
|
7 Application of actinobacteria as probiotics in livestock and poultry production |
|
|
359 | (1) |
|
|
360 | (1) |
|
|
360 | (5) |
|
23 Small- and Large-Scale Production of Probiotic Foods, Probiotic Potential and Nutritional Benefits |
|
|
|
|
|
|
|
|
365 | (1) |
|
2 Role of probiotics in food fermentation |
|
|
366 | (1) |
|
3 Production of probiotic foods |
|
|
367 | (1) |
|
|
367 | (3) |
|
|
367 | (1) |
|
|
368 | (1) |
|
4.3 Probiotic value of kimchi |
|
|
368 | (1) |
|
4.4 Health benefits of kimchi |
|
|
369 | (1) |
|
|
370 | (3) |
|
5.1 Manufacture of tempeh |
|
|
371 | (1) |
|
5.2 Health benefits of tempeh |
|
|
372 | (1) |
|
|
373 | (3) |
|
6.1 Probiotic potential of kombucha |
|
|
374 | (1) |
|
6.2 Biochemical profile of kombucha tea |
|
|
374 | (1) |
|
6.3 Health benefits of kombucha |
|
|
375 | (1) |
|
|
376 | (3) |
|
7.1 Probiotic value of kefir |
|
|
376 | (1) |
|
|
377 | (1) |
|
7.3 Health benefits of kefir |
|
|
377 | (2) |
|
|
379 | (2) |
|
8.1 Production of sauerkraut |
|
|
379 | (1) |
|
8.2 Nutritional profile of sauerkraut |
|
|
380 | (1) |
|
8.3 Health benefits of sauerkraut |
|
|
380 | (1) |
|
|
381 | (2) |
|
9.1 Production of pickles |
|
|
382 | (1) |
|
9.2 Health benefits of pickle |
|
|
382 | (1) |
|
|
383 | (1) |
|
|
383 | (1) |
|
10.2 Nutritional profile and health benefits |
|
|
383 | (1) |
|
|
384 | (1) |
|
|
384 | (1) |
|
11.2 Nutritional profile and health benefits |
|
|
384 | (1) |
|
|
384 | (2) |
|
12.1 Production of yoghurt |
|
|
385 | (1) |
|
12.2 Nutritional profile and health benefits |
|
|
386 | (1) |
|
|
386 | (1) |
|
13.1 Health benefits of dosa |
|
|
387 | (1) |
|
|
387 | (1) |
|
|
387 | (10) |
|
24 Lactic Acid Bacteria in Fermented Food |
|
|
|
|
|
397 | (1) |
|
2 The probiotics microorganism used in the fermented food |
|
|
398 | (15) |
|
|
398 | (1) |
|
2.2 Nonpathogenic Corynebacterium |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
399 | (5) |
|
|
404 | (1) |
|
2.6 Fermented vegetable food microorganism |
|
|
405 | (5) |
|
2.7 Microorganism in fermented dairy products |
|
|
410 | (1) |
|
2.8 Fermented meat and fish |
|
|
410 | (1) |
|
2.9 Microorganism in fermented grain-based foods |
|
|
410 | (1) |
|
|
410 | (1) |
|
|
411 | (2) |
|
3 Function and application of food microorganisms |
|
|
413 | (1) |
|
3.1 Health function of probiotics microorganisms |
|
|
413 | (1) |
|
3.2 Diseases caused by intestinal flora imbalance |
|
|
414 | (1) |
|
|
414 | (1) |
|
|
414 | (3) |
|
25 Commercially Available Probiotics and Prebiotics Used in Human and Animal Nutrition |
|
|
|
|
|
|
|
|
|
417 | (1) |
|
2 Probiotic microorganisms used in human nutrition and their role |
|
|
418 | (5) |
|
2.1 Lactobacillus species |
|
|
418 | (3) |
|
2.2 Bifidobacterium species |
|
|
421 | (2) |
|
|
423 | (1) |
|
3 Probiotic microorganisms used in animal nutrition and their role |
|
|
423 | (4) |
|
|
424 | (1) |
|
|
424 | (1) |
|
|
425 | (1) |
|
|
425 | (2) |
|
4 Prebiotics used in human and animal nutrition |
|
|
427 | (2) |
|
|
427 | (1) |
|
4.2 Galacto-oligosaccharides (GOS) |
|
|
428 | (1) |
|
4.3 Resistant starch (RS) and glucose-derived oligosaccharides |
|
|
428 | (1) |
|
4.4 Miscellaneous oligosaccharides |
|
|
429 | (1) |
|
|
429 | (1) |
|
4.6 Non-carbohydrates prebiotics |
|
|
429 | (1) |
|
|
429 | (1) |
|
|
429 | (8) |
|
26 New Formulations and Products in Prebiotic Food |
|
|
|
Mohamed Yousuff Mohamed Imran |
|
|
|
|
|
Dharumadurai Dhanasekaran |
|
|
|
437 | (1) |
|
2 Prebiotic dietary fiber sources |
|
|
438 | (1) |
|
|
438 | (1) |
|
2.2 Inulin, oligofructose, and FOSS |
|
|
438 | (1) |
|
|
438 | (1) |
|
2.4 Isomaltooligosaccharides |
|
|
438 | (1) |
|
|
438 | (1) |
|
|
438 | (1) |
|
|
438 | (1) |
|
2.8 Xylooligosaccharides and arabinooligosaccharides |
|
|
439 | (1) |
|
3 Prebiotic production from food industry wastes and agricultural by-products |
|
|
439 | (1) |
|
4 Development of prebiotic food products |
|
|
439 | (3) |
|
|
442 | (1) |
|
6 Food applications of prebiotics |
|
|
443 | (1) |
|
|
444 | (1) |
|
|
445 | (4) |
|
27 Therapeutic Potential of Different Probiotic Foods |
|
|
|
|
|
|
449 | (1) |
|
|
449 | (1) |
|
|
449 | (1) |
|
|
450 | (1) |
|
2 Criteria for the selection of probiotic food |
|
|
450 | (1) |
|
3 Different types of probiotic food |
|
|
450 | (20) |
|
3.1 Classification of fermented food is based on different substrates |
|
|
450 | (1) |
|
3.2 Milk-based: Yogurt, cheese, and kefir |
|
|
450 | (7) |
|
3.3 Cereal- and legume-based: idli, dosa, appam |
|
|
457 | (2) |
|
3.4 Legume-based: tempeh, miso |
|
|
459 | (2) |
|
3.5 Vegetable- and fruit-based: kombucha, pickles, kimchi, and sauerkraut |
|
|
461 | (9) |
|
|
470 | (1) |
|
|
470 | (9) |
|
28 Main Technological Challenges Associated With the Incorporation of Probiotic Cultures into Foods |
|
|
|
|
|
|
|
|
1 Introduction to probiotic-containing functional foods |
|
|
479 | (1) |
|
2 Probiotic foods on the market |
|
|
480 | (1) |
|
3 Factors affecting probiotics' viability |
|
|
481 | (3) |
|
|
481 | (2) |
|
3.2 Processing conditions |
|
|
483 | (1) |
|
3.3 Competition with starter cultures |
|
|
483 | (1) |
|
|
484 | (1) |
|
|
484 | (1) |
|
4 Intervention strategies |
|
|
484 | (6) |
|
4.1 Strain selection and inoculation condition |
|
|
484 | (2) |
|
|
486 | (2) |
|
4.3 Addition of protective ingredients |
|
|
488 | (1) |
|
|
489 | (1) |
|
|
490 | (1) |
|
|
491 | (6) |
|
29 Effective Probiotic Delivery: Current Trends and Future Perspectives |
|
|
|
|
|
|
497 | (1) |
|
|
498 | (1) |
|
|
498 | (1) |
|
|
498 | (1) |
|
3 Selection of probiotic strains for technological performance |
|
|
499 | (1) |
|
|
499 | (1) |
|
|
499 | (1) |
|
|
500 | (1) |
|
3.4 Temperature tolerance |
|
|
500 | (1) |
|
4 Use of encapsulation technology for effective delivery of probiotics |
|
|
500 | (3) |
|
4.1 Significance of cell survival during processing and storage |
|
|
502 | (1) |
|
4.2 Significance of cell survival during GIT transit |
|
|
502 | (1) |
|
4.3 Improvement of sensory characters and limitations |
|
|
503 | (1) |
|
5 Microencapsulation of probiotics |
|
|
503 | (3) |
|
5.1 Efficient matrices for microencapsulation of probiotics |
|
|
503 | (1) |
|
5.2 Effective encapsulation methods |
|
|
504 | (2) |
|
6 Nanoencapsulation of probiotics |
|
|
506 | (2) |
|
6.1 Lipid-based nanocarriers |
|
|
507 | (1) |
|
6.2 Nature-inspired nanocarriers |
|
|
507 | (1) |
|
6.3 Special equipment-based nanocarriers |
|
|
507 | (1) |
|
6.4 Biopolymer-based nanocarriers |
|
|
508 | (1) |
|
7 Encapsulation of probiotics: insights into industrial applications |
|
|
508 | (1) |
|
8 Conclusion and future perspectives |
|
|
509 | (2) |
|
|
511 | (8) |
|
30 Industrial Requirements and Other Techno-functional Traits of Probiotics |
|
|
|
Govindan Nadar Rajivgandhi |
|
|
|
|
|
|
519 | (1) |
|
1.1 Characteristics of probiotics |
|
|
520 | (1) |
|
2 Health benefits of probiotics |
|
|
520 | (2) |
|
3 The techno-functional traits approaches of probiotics |
|
|
522 | (3) |
|
3.1 Functional aspects of probiotics |
|
|
523 | (1) |
|
|
523 | (1) |
|
3.3 Antagonistic properties |
|
|
523 | (1) |
|
3.4 Immunomodulatory properties |
|
|
524 | (1) |
|
3.5 Improved barrier function |
|
|
524 | (1) |
|
3.6 Anti-inflammatory properties |
|
|
524 | (1) |
|
3.7 Antimutagenic and anticarcinogenic properties |
|
|
524 | (1) |
|
4 Industry-based probiotics application in various fields |
|
|
525 | (1) |
|
4.1 Food applications of probiotics |
|
|
525 | (1) |
|
4.2 Dairy-based probiotic foods |
|
|
525 | (1) |
|
4.3 Fresh milk and fermented milks |
|
|
525 | (1) |
|
4.4 Other dairy-based products |
|
|
525 | (1) |
|
4.5 Fruit-based probiotic products |
|
|
526 | (1) |
|
4.6 Cereal-based probiotic products |
|
|
526 | (1) |
|
4.7 Meat-based probiotic foods |
|
|
526 | (1) |
|
5 Agricultural applications of probiotics |
|
|
526 | (1) |
|
6 Livestock applications of probiotics |
|
|
527 | (1) |
|
7 Probiotics application challenges |
|
|
527 | (1) |
|
7.1 Viability and survival |
|
|
527 | (1) |
|
|
528 | (1) |
|
8 The future of probiotics |
|
|
528 | (1) |
|
9 Regulations and guidelines for probiotics |
|
|
529 | (1) |
|
9.1 Safety aspects and harmful side effects of probiotics |
|
|
529 | (1) |
|
|
530 | (1) |
|
|
530 | (5) |
Index |
|
535 | |